WO2023078419A1 - Polyurethane acrylate, photocurable material, preparation method and use - Google Patents

Polyurethane acrylate, photocurable material, preparation method and use Download PDF

Info

Publication number
WO2023078419A1
WO2023078419A1 PCT/CN2022/130021 CN2022130021W WO2023078419A1 WO 2023078419 A1 WO2023078419 A1 WO 2023078419A1 CN 2022130021 W CN2022130021 W CN 2022130021W WO 2023078419 A1 WO2023078419 A1 WO 2023078419A1
Authority
WO
WIPO (PCT)
Prior art keywords
acrylate
polyether
preparation
polyester polyol
reaction
Prior art date
Application number
PCT/CN2022/130021
Other languages
French (fr)
Chinese (zh)
Inventor
覃章友
Original Assignee
广州黑格智造信息科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 广州黑格智造信息科技有限公司 filed Critical 广州黑格智造信息科技有限公司
Publication of WO2023078419A1 publication Critical patent/WO2023078419A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/42Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4244Polycondensates having carboxylic or carbonic ester groups in the main chain containing oxygen in the form of ether groups
    • C08G18/4247Polycondensates having carboxylic or carbonic ester groups in the main chain containing oxygen in the form of ether groups derived from polyols containing at least one ether group and polycarboxylic acids
    • C08G18/4252Polycondensates having carboxylic or carbonic ester groups in the main chain containing oxygen in the form of ether groups derived from polyols containing at least one ether group and polycarboxylic acids derived from polyols containing polyether groups and polycarboxylic acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00Materials specially adapted for additive manufacturing
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/46Polymerisation initiated by wave energy or particle radiation
    • C08F2/48Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F283/00Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G
    • C08F283/006Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G on to polymers provided for in C08G18/00
    • C08F283/008Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G on to polymers provided for in C08G18/00 on to unsaturated polymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/4009Two or more macromolecular compounds not provided for in one single group of groups C08G18/42 - C08G18/64
    • C08G18/4018Mixtures of compounds of group C08G18/42 with compounds of group C08G18/48
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/42Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4266Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
    • C08G18/4269Lactones
    • C08G18/4277Caprolactone and/or substituted caprolactone
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/48Polyethers
    • C08G18/4825Polyethers containing two hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/67Unsaturated compounds having active hydrogen
    • C08G18/671Unsaturated compounds having only one group containing active hydrogen
    • C08G18/672Esters of acrylic or alkyl acrylic acid having only one group containing active hydrogen

Abstract

The present application discloses a polyurethane acrylate, a photocuring material, a preparation method and a use, and a method for fabricating an oral medical device. A polyether/polyester polyol soft segment having a special structure is introduced into the polyurethane acrylate, so that the polyurethane acrylate has the characteristics of low haze, high transmittance and high toughness. By combining bio-based polyurethane acrylate, high-strength aliphatic urethane acrylate, a monofunctional free radical acrylate monomer and a bifunctional free radical acrylate monomer, after curing, the photocurable material has a very suitable crosslinking density, good mechanical strength, good dimensional stability, excellent aging resistance, low haze, and high transmittance.

Description

聚氨酯丙烯酸酯、光固化材料及制备方法和应用Polyurethane acrylate, photocurable material, preparation method and application
相关申请的交叉引用Cross References to Related Applications
本申请要求于2021年11月05日提交中国专利局的申请号为202111308532.8、名称为“低雾度高韧性聚氨酯丙烯酸酯、光固化材料及其制备方法和应用”的中国专利申请的优先权,其全部内容通过引用结合在本申请中。This application claims the priority of the Chinese patent application with application number 202111308532.8 and titled "Low Haze High Toughness Urethane Acrylate, Light Curing Material and Its Preparation and Application" submitted to the China Patent Office on November 05, 2021. The entire contents of which are incorporated by reference in this application.
技术领域technical field
本申请涉及高分子技术领域,特别涉及一种聚氨酯丙烯酸酯及其制备方法、光固化材料及其制备方法、光固化材料在制作口腔医疗器械中的应用、口腔医疗器械的制作方法。The present application relates to the field of polymer technology, in particular to a polyurethane acrylate and a preparation method thereof, a photocurable material and a preparation method thereof, the application of the photocurable material in making oral medical devices, and a method for manufacturing oral medical devices.
背景技术Background technique
3D打印技术通常也叫做增材制造或者是增量制造,是建立在三维数学模型的数据基础之上,主要是利用连续的分层打印并且通过一层层的叠加,最终形成三维实体的技术。作为一个高度定制化的行业,牙科在向数字化转型的过程中与3D打印有着密切的关系。在口腔医学领域,3D打印技术受到越来越广泛的应用以及研究,其中口腔修复学、口腔种植学、口腔正畸学、口腔内科学都有涉及,还包括生产用于牙科种植导板、颅颌面和整形外科植入物的制造,以及用于植入物和牙齿修复体的内冠和骨架的制造等等。3D printing technology is usually also called additive manufacturing or incremental manufacturing. It is based on the data of three-dimensional mathematical models. It mainly uses continuous layer printing and superimposes layers to form a three-dimensional entity. As a highly customized industry, dentistry has a close relationship with 3D printing in its transition to digital. In the field of stomatology, 3D printing technology is being applied and researched more and more widely, including prosthodontics, dental implantology, orthodontics, and oral medicine, and also includes the production of dental implant guides, cranial jaws, etc. Fabrication of facial and orthopedic implants, as well as copings and frameworks for implants and dental restorations, among others.
随着口腔医学的不断发展,3D打印在牙科上的应用更加深入,关于牙科3D打印材料的研究已成为许多研究者的研究重点,近年来取得了较大突破,不断有新型3D打印材料应用于口腔医学领域。但是目前的3D打印牙科材料透明成品,包括咬合夹板、手术导板、保持器、正畸矫治器,直接打印的隐形牙套等还存在雾度偏高,透过率偏低,生物相容性差,医用风险,韧性差,尺寸稳定性差等一系列问题,导致普及率还远远不够。With the continuous development of stomatology, the application of 3D printing in dentistry has become more in-depth. The research on dental 3D printing materials has become the research focus of many researchers. In recent years, great breakthroughs have been made. The field of stomatology. However, the current transparent products of 3D printed dental materials, including occlusal splints, surgical guides, retainers, orthodontic appliances, and directly printed invisible braces, still have high haze, low transmittance, and poor biocompatibility. A series of problems such as risk, poor toughness, and poor dimensional stability have caused the penetration rate to be far from enough.
发明内容Contents of the invention
本申请旨在至少解决现有技术中存在的技术问题之一。为此,本申请提出一种聚 氨酯丙烯酸酯及其制备方法、光固化材料及其制备方法、光固化材料在制作口腔医疗器械中的应用、口腔医疗器械的制作方法,能够降低所制作的物件如口腔医疗器械的雾度、提高透过率和韧性。This application aims to solve at least one of the technical problems existing in the prior art. For this reason, the application proposes a kind of urethane acrylate and its preparation method, light-cured material and its preparation method, the application of light-cured material in making oral medical device, the manufacturing method of oral medical device, can reduce the object made such as Haze of dental medical devices, improve transmittance and toughness.
为了实现上述目的,根据本申请的一个方面,提供了一种聚氨酯丙烯酸酯,该聚氨酯丙烯酸酯含有聚醚/聚酯多元醇的结构单元,聚醚/聚酯多元醇具有如下式I、式II、式III中的至少一种结构式:In order to achieve the above object, according to one aspect of the present application, a kind of polyurethane acrylate is provided, this polyurethane acrylate contains the structural unit of polyether/polyester polyol, and polyether/polyester polyol has following formula I, formula II , at least one structural formula in formula III:
Figure PCTCN2022130021-appb-000001
Figure PCTCN2022130021-appb-000001
其中,n为1-1000的整数。Wherein, n is an integer of 1-1000.
根据本申请的另一方面,提供了一种前述聚氨酯丙烯酸酯的制备方法,该制备方法包括如下步骤:使聚醚/聚酯多元醇与丙烯酸-2-羟乙酯、新戊二醇、甲基丙烯酸羟乙酯和异氰酸酯进行本体聚合,得到聚氨酯丙烯酸酯;聚醚/聚酯多元醇具有如下式I、式II、式III中的至少一种结构式:According to another aspect of the present application, a kind of preparation method of aforementioned polyurethane acrylate is provided, and this preparation method comprises the following steps: make polyether/polyester polyol and acrylate-2-hydroxyethyl ester, neopentyl glycol, methyl Hydroxyethyl acrylate and isocyanate are bulk polymerized to obtain polyurethane acrylate; polyether/polyester polyol has at least one structural formula in the following formula I, formula II, and formula III:
Figure PCTCN2022130021-appb-000002
Figure PCTCN2022130021-appb-000002
Figure PCTCN2022130021-appb-000003
Figure PCTCN2022130021-appb-000003
其中,n为1-1000的整数。Wherein, n is an integer of 1-1000.
根据本申请的又一方面,提供了一种光固化材料,该光固化材料包括上述的聚氨酯丙烯酸酯。According to still another aspect of the present application, a photocurable material is provided, the photocurable material includes the above-mentioned urethane acrylate.
根据本申请的又一方面,提供了一种光固化材料的制备方法,该光固化材料包括聚氨酯丙烯酸酯,该制备方法包括上述的聚氨酯丙烯酸酯的制备方法。According to still another aspect of the present application, a method for preparing a photocurable material is provided, the photocurable material includes urethane acrylate, and the preparation method includes the above-mentioned method for preparing urethane acrylate.
根据本申请的又一方面,提供了一种前述光固化材料在制作口腔医疗器械中的应用。According to yet another aspect of the present application, an application of the aforementioned light-curing material in making oral medical devices is provided.
根据本申请的又一方面,提供了一种口腔医疗器械的制作方法,该制作方法包括如下步骤:以上述光固化材料为原料,成型后进行光固化,得到口腔医疗器械。According to yet another aspect of the present application, a method for manufacturing an oral medical device is provided. The manufacturing method includes the following steps: using the above-mentioned photo-curable material as a raw material, and performing photo-curing after molding to obtain an oral medical device.
本申请的聚氨酯丙烯酸酯含有无规的、组成复杂的聚醚/聚酯多元醇软段,该聚醚/聚酯多元醇软段的序列结构无序,柔韧性极佳,聚醚/聚酯多元醇软段中的亚聚氧化丙烯基由于侧甲基影响,分子规整性较差,不易结晶,所以大幅度降低了整体的结晶度,从而在应用于光固化材料并进行光固化成型后,能够大幅度提高成型物件的透光度、韧性,并能够降低雾度。The urethane acrylate of the present application contains random and complex polyether/polyester polyol soft segments. The sequence structure of the polyether/polyester polyol soft segments is disordered and has excellent flexibility. Polyether/polyester Due to the influence of the side methyl group, the subpolyoxypropylene group in the polyol soft segment has poor molecular regularity and is not easy to crystallize, so the overall crystallinity is greatly reduced. It can greatly improve the light transmittance and toughness of molded objects, and can reduce haze.
附图说明Description of drawings
为了更清楚地说明本申请实施例的技术方案,下面将对实施例中所需要使用的附图作简单地介绍,应当理解,以下附图仅示出了本申请的某些实施例,因此不应被看作是对范围的限定,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他相关的附图。In order to more clearly illustrate the technical solutions of the embodiments of the present application, the following will briefly introduce the accompanying drawings used in the embodiments. It should be understood that the following drawings only show some embodiments of the present application, so It should be regarded as a limitation on the scope, and those skilled in the art can also obtain other related drawings based on these drawings without creative work.
图1为成品/导环匹配性检测照片。Figure 1 is a photo of the matching test of the finished product/guide ring.
具体实施方式Detailed ways
以下结合具体的实施例进一步说明本申请的技术方案。以下实施例中所用的原料,如无特殊说明,均可从常规商业途径得到;所采用的工艺,如无特殊说明,均采用本领域的常规工艺。The technical solution of the present application will be further described below in conjunction with specific examples. The raw materials used in the following examples, unless otherwise specified, can be obtained from conventional commercial channels; the processes used, unless otherwise specified, are conventional processes in the art.
本申请提供一种聚氨酯丙烯酸酯,在一些实施例中,该聚氨酯丙烯酸酯含有聚醚/聚酯多元醇的结构单元。其中,聚醚/聚酯多元醇具有如下式I、式II、式III中的至少一种结构式:The present application provides a polyurethane acrylate. In some embodiments, the polyurethane acrylate contains polyether/polyester polyol structural units. Wherein, polyether/polyester polyol has at least one structural formula in following formula I, formula II, formula III:
Figure PCTCN2022130021-appb-000004
Figure PCTCN2022130021-appb-000004
其中,n为1-1000的整数,例如可以是10-1000的整数。Wherein, n is an integer of 1-1000, for example, may be an integer of 10-1000.
需要说明的是,上述的聚氨酯丙烯酸酯含有式I、式II、式III中的无规的、组成复杂的聚醚/聚酯多元醇软段,该聚醚/聚酯多元醇软段的序列结构无序,柔韧性极佳;此外,聚醚/聚酯多元醇软段中的亚聚氧化丙烯基由于侧甲基影响,分子规整性较差,不易结晶,所以大幅度降低了整体的结晶度,从而大幅度提高了透光度,降低了雾度,并具有高韧性。It should be noted that the above-mentioned urethane acrylate contains random and complex polyether/polyester polyol soft segments in formula I, formula II, and formula III, and the sequence of the polyether/polyester polyol soft segments The structure is disordered and the flexibility is excellent; in addition, due to the influence of the side methyl group, the sub-polyoxypropylene group in the soft segment of polyether/polyester polyol has poor molecular regularity and is not easy to crystallize, so the overall crystallization is greatly reduced degree, which greatly improves the light transmittance, reduces the haze, and has high toughness.
在一些实施方式中,聚氨酯丙烯酸酯含有如下式IV所示的链段:In some embodiments, urethane acrylate contains a chain segment shown in the following formula IV:
Figure PCTCN2022130021-appb-000005
Figure PCTCN2022130021-appb-000005
其中,R0为
Figure PCTCN2022130021-appb-000006
R 1、R 1’分别独立地选自
Figure PCTCN2022130021-appb-000007
R 1a、R 1b分别独立地选自H或C 1-3烷基;R 2为聚醚/聚酯多元醇的结构单元。需要指出的是,本申请中所述的“独立地选自”表示对于主体的选项的选择互不干扰,例如,R 1a、R 1b分别独立地选自H或C 1-3烷基,表示R 1a选自H或C 1-3烷基,R 1b选自H或C 1-3烷基。
Among them, R0 is
Figure PCTCN2022130021-appb-000006
R 1 , R 1 ' are independently selected from
Figure PCTCN2022130021-appb-000007
R 1a and R 1b are independently selected from H or C 1-3 alkyl; R 2 is a structural unit of polyether/polyester polyol. It should be pointed out that the "independently selected from" mentioned in this application means that the selection of the options of the main body does not interfere with each other, for example, R 1a and R 1b are independently selected from H or C 1-3 alkyl, representing R 1a is selected from H or C 1-3 alkyl, R 1b is selected from H or C 1-3 alkyl.
在一些实施方式中,R 1、R 1’分别独立地选自
Figure PCTCN2022130021-appb-000008
Figure PCTCN2022130021-appb-000009
In some embodiments, R 1 and R 1 ' are independently selected from
Figure PCTCN2022130021-appb-000008
Figure PCTCN2022130021-appb-000009
在一些实施方式中,R 1、R 1’均选自
Figure PCTCN2022130021-appb-000010
R 2为式I所示聚醚/聚酯多元醇的结构单元。
In some embodiments, both R 1 and R 1 ' are selected from
Figure PCTCN2022130021-appb-000010
R 2 is a structural unit of polyether/polyester polyol shown in formula I.
在一些实施方式中,R 1、R 1’均选自
Figure PCTCN2022130021-appb-000011
R 2为式II所示聚醚/聚酯多元醇的结构单元。
In some embodiments, both R 1 and R 1 ' are selected from
Figure PCTCN2022130021-appb-000011
R 2 is a structural unit of polyether/polyester polyol represented by formula II.
在一些实施方式中,R 1、R 1’均选自
Figure PCTCN2022130021-appb-000012
R 2为式III所示聚醚/聚酯多元醇的结构单元。
In some embodiments, both R 1 and R 1 ' are selected from
Figure PCTCN2022130021-appb-000012
R 2 is a structural unit of polyether/polyester polyol represented by formula III.
在一些实施方式中,聚氨酯丙烯酸酯的ASTM雾度小于10%,透过率大于85%,聚氨酯丙烯酸酯的缺口冲击强度大于60J/M。当然,在其它实施例中,聚氨酯丙烯酸酯的性能也可满足其中的一者或两者。In some embodiments, the ASTM haze of the urethane acrylate is less than 10%, the transmittance is greater than 85%, and the notched impact strength of the urethane acrylate is greater than 60 J/M. Of course, in other embodiments, the properties of urethane acrylate can also satisfy one or both of them.
在一些实施方式中,聚醚/聚酯多元醇由脂肪二元酸、芳香二元酸、聚氧化丙烯二醇、多元醇经无规共聚得到。In some embodiments, polyether/polyester polyols are obtained by random copolymerization of fatty dibasic acids, aromatic dibasic acids, polyoxypropylene diols, and polyols.
需要说明的是,上述原料通过无规共聚可形成主链相对无规的聚醚/聚酯多元醇软段,其组成比常规共聚更加复杂,序列结构更加无序,柔韧性极佳,并且共聚过程中芳香二元酸的引入有效的破坏了聚醚/聚酯多元醇的序列结构,而且聚氧化丙烯二醇(PPG)形成的聚氧化丙烯二醇软段由于侧甲基影响,分子规整性较差,不易结晶,所以大幅度降低了整体的结晶度,从而大幅度提高了透光度,降低了雾度。It should be noted that the above-mentioned raw materials can form a relatively random polyether/polyester polyol soft segment with a main chain through random copolymerization. The introduction of aromatic dibasic acid in the process effectively destroys the sequence structure of polyether/polyester polyol, and the polyoxypropylene glycol soft segment formed by polyoxypropylene glycol (PPG) has molecular regularity due to the influence of side methyl groups. It is poor and not easy to crystallize, so the overall crystallinity is greatly reduced, thereby greatly improving the light transmittance and reducing the haze.
在一些实施方式中,脂肪二元酸包括己二酸。In some embodiments, the fatty dibasic acid includes adipic acid.
在一些实施方式中,芳香二元酸包括对苯二甲酸、邻苯二甲酸中的至少一种。In some embodiments, the aromatic dibasic acid includes at least one of terephthalic acid and phthalic acid.
在一些实施方式中,聚氧化丙烯二醇的分子量为300-600,具体如300-500。In some embodiments, the polyoxypropylene diol has a molecular weight of 300-600, specifically 300-500.
在一些实施方式中,多元醇包括一缩二乙二醇。In some embodiments, the polyol includes diethylene glycol.
在一些实施方式中,聚氧化丙烯二醇、多元醇的总摩尔数m1,与脂肪二元酸和芳香二元酸的总摩尔数m2的比例m1∶m2=1-2∶1,如1.5-1.8∶1,具体如1.52-1.71∶1,例如1.52∶1、1.55∶1、1.60∶1、1.65∶1、1.71∶1等。In some embodiments, the ratio of the total moles m1 of polyoxypropylene diol and polyol to the total moles m2 of fatty dibasic acids and aromatic dibasic acids m1:m2=1-2:1, such as 1.5- 1.8:1, specifically 1.52-1.71:1, such as 1.52:1, 1.55:1, 1.60:1, 1.65:1, 1.71:1, etc.
在一些实施方式中,脂肪二元酸与芳香二元酸的摩尔比为1∶1-3,具体如1∶3、1∶2、1∶1等。In some embodiments, the molar ratio of fatty dibasic acid to aromatic dibasic acid is 1:1-3, specifically 1:3, 1:2, 1:1, etc.
在一些实施方式中,芳香二元酸为对苯二甲酸、邻苯二甲酸的组合,脂肪二元酸、对苯二甲酸和邻苯二甲酸的摩尔比为1∶0.5-1.5∶0.5-1.5,具体如1∶1∶1、1∶0.5∶0.5、1∶1.5∶1.5、1∶1.2∶1.3、1∶0.8∶0.6等。In some embodiments, the aromatic dibasic acid is a combination of terephthalic acid and phthalic acid, and the molar ratio of fatty dibasic acid, terephthalic acid and phthalic acid is 1:0.5-1.5:0.5-1.5 , specifically such as 1:1:1, 1:0.5:0.5, 1:1.5:1.5, 1:1.2:1.3, 1:0.8:0.6, etc.
在一些实施方式中,聚氧化丙烯二醇与多元醇的摩尔比为1∶0.5-1.5,具体如1∶1、1∶0.5、1∶1.5、1∶0.8、1∶1.3等。In some embodiments, the molar ratio of polyoxypropylene diol to polyol is 1:0.5-1.5, specifically 1:1, 1:0.5, 1:1.5, 1:0.8, 1:1.3, etc.
在一些实施方式中,聚醚/聚酯多元醇的制备方法包括如下步骤:In some embodiments, the preparation method of polyether/polyester polyol comprises the steps:
将脂肪二元酸、芳香二元酸、聚氧化丙烯二醇和多元醇混合,进行无规共聚酯化反应,得到无规共聚酯化产物;使无规共聚酯化产物在抽真空、酸催化条件下反应至酸值小于1mgKOH/g,得到聚醚/聚酯多元醇。Mix aliphatic dibasic acid, aromatic dibasic acid, polyoxypropylene diol and polyol, and carry out random copolyesterification reaction to obtain random copolyesterification product; make random copolyesterification product in vacuum, React under acid catalyzed conditions until the acid value is less than 1 mgKOH/g to obtain polyether/polyester polyol.
在一些实施方式中,无规共聚酯化反应的温度为90-160℃,如90℃、100℃、110℃、 120℃、130℃、140℃、150℃、160℃等,时间为2-4h,如2h、3h、4h等。In some embodiments, the temperature of the random copolyesterification reaction is 90-160°C, such as 90°C, 100°C, 110°C, 120°C, 130°C, 140°C, 150°C, 160°C, etc., and the time is 2 -4h, such as 2h, 3h, 4h, etc.
在一些实施方式中,无规共聚酯化产物在抽真空、酸催化条件下的反应温度为180-230℃,如180℃、190℃、200℃、210℃、220℃、230℃等,反应时间为1-4h,如1h、2h、3h、4h等,真空度为0.08-0.09MPa。In some embodiments, the reaction temperature of the random copolyesterification product under vacuum and acid-catalyzed conditions is 180-230°C, such as 180°C, 190°C, 200°C, 210°C, 220°C, 230°C, etc., The reaction time is 1-4h, such as 1h, 2h, 3h, 4h, etc., and the vacuum degree is 0.08-0.09MPa.
在一些实施方式中,聚氨酯丙烯酸酯由聚醚/聚酯多元醇与丙烯酸-2-羟乙酯(HEA)、新戊二醇(NPG)、甲基丙烯酸羟乙酯(HEMA)、异氰酸酯经本体聚合得到。In some embodiments, urethane acrylate is prepared from polyether/polyester polyol and 2-hydroxyethyl acrylate (HEA), neopentyl glycol (NPG), hydroxyethyl methacrylate (HEMA), isocyanate via bulk aggregated.
聚醚/聚酯多元醇通过和HEA、NPG、HEMA、异氰酸酯进行本体聚合工艺,可通过控制反应温度和摩尔比,催化剂等工艺条件,合成高透过率低雾度高韧性的脂肪族聚氨酯丙烯酸酯。而且,通过在分子链中引入NPG,可使该聚氨酯丙烯酸酯的结晶度更低。Polyether/polyester polyols are polymerized with HEA, NPG, HEMA, and isocyanate in bulk, and aliphatic polyurethane acrylic acid with high transmittance, low haze, and high toughness can be synthesized by controlling the reaction temperature, molar ratio, catalyst and other process conditions. ester. Moreover, by introducing NPG into the molecular chain, the crystallinity of the urethane acrylate can be lowered.
在一些实施方式中,聚醚/聚酯多元醇、新戊二醇的总-OH与异氰酸酯中的-NCO的摩尔比为1∶0.5-2,例如1∶1.5-2,具体如1∶1.5、1∶2、1∶1.7等。In some embodiments, the molar ratio of the total -OH of polyether/polyester polyol and neopentyl glycol to the -NCO in isocyanate is 1:0.5-2, for example 1:1.5-2, specifically 1:1.5 , 1:2, 1:1.7, etc.
在一些实施方式中,聚醚/聚酯多元醇与新戊二醇的摩尔比为1∶0.5-1.5,如1∶1.5、1∶1.2、1∶1、1∶0.5、1∶1等。In some embodiments, the molar ratio of polyether/polyester polyol to neopentyl glycol is 1:0.5-1.5, such as 1:1.5, 1:1.2, 1:1, 1:0.5, 1:1, etc.
在一些实施方式中,聚醚/聚酯多元醇、丙烯酸-2-羟乙酯、新戊二醇和甲基丙烯酸羟乙酯的总-OH与异氰酸酯中的-NCO摩尔数相等。In some embodiments, the total -OH of the polyether/polyester polyol, 2-hydroxyethyl acrylate, neopentyl glycol, and hydroxyethyl methacrylate is equal to the number of moles of -NCO in the isocyanate.
在一些实施方式中,异氰酸酯具有不对称结构,包括异佛尔酮二异氰酸酯(IPDI)。使用的IPDI由于分子结构不对称,也不易形成结晶,使得低聚物有很高的透过低,极低的雾度,和极佳的弹性与韧性。在实际操作中,根据聚氨酯丙烯酸酯的应用,可选择合适安全级别的IPDI。如将聚氨酯丙烯酸酯应用于制作口腔器材时,其中IPDI选自FDA认证的可用于食品接触应用的食品级IPDI固化剂。In some embodiments, the isocyanate has an asymmetric structure, including isophorone diisocyanate (IPDI). Due to the asymmetric molecular structure of the IPDI used, it is not easy to form crystals, so that the oligomer has a high low permeability, extremely low haze, and excellent elasticity and toughness. In actual operation, according to the application of urethane acrylate, IPDI with appropriate safety level can be selected. For example, when urethane acrylate is used to make oral equipment, IPDI is selected from FDA-certified food-grade IPDI curing agents that can be used in food contact applications.
本申请的第二方面是提供聚氨酯丙烯酸酯的制备方法,包括如下步骤:使聚醚/聚酯多元醇与丙烯酸-2-羟乙酯、新戊二醇、甲基丙烯酸羟乙酯和异氰酸酯进行本体聚合,得到低雾度高韧性的聚氨酯丙烯酸酯。The second aspect of the present application is to provide the preparation method of polyurethane acrylate, comprising the steps of: making polyether/polyester polyol and acrylate-2-hydroxyethyl ester, neopentyl glycol, hydroxyethyl methacrylate and isocyanate Bulk polymerization to obtain polyurethane acrylate with low haze and high toughness.
更具体地,聚氨酯丙烯酸酯的制备方法可包括如下步骤:将聚醚/聚酯多元醇与新戊二醇、异氰酸酯混合,反应至少体系无-OH残留,得到第一反应物;将第一反应物与丙烯酸-2-羟乙酯、甲基丙烯酸羟乙酯混合,反应至体系无-NCO残留,得到低雾度高韧性的聚氨酯丙烯酸酯。More specifically, the preparation method of polyurethane acrylate may include the following steps: mixing polyether/polyester polyol with neopentyl glycol and isocyanate, and reacting at least the system without -OH residues to obtain the first reactant; The product is mixed with 2-hydroxyethyl acrylate and hydroxyethyl methacrylate, and reacted until there is no -NCO residue in the system, and a polyurethane acrylate with low haze and high toughness is obtained.
需要说明的是,各反应原料的特征及占比与前述实施方式中的相似,相关详细内容请参阅上述实施方式,此处不再赘述。It should be noted that the characteristics and proportions of each reaction raw material are similar to those in the aforementioned embodiments, and relevant details can be found in the aforementioned embodiments, and will not be repeated here.
在一些实施方式中,聚醚/聚酯多元醇、新戊二醇和异氰酸酯的反应温度为30-70℃,如30℃、40℃、50℃、60℃、70℃等。在实际操作中,将异氰酸酯滴加到聚醚/聚酯多元醇、新戊二醇的混合物中,然后进行反应,控制滴加速度,滴加时长为1-2h,如1h、1.2h、1.4、1.6h、1.8h、2h等。In some embodiments, the reaction temperature of polyether/polyester polyol, neopentyl glycol and isocyanate is 30-70°C, such as 30°C, 40°C, 50°C, 60°C, 70°C, etc. In actual operation, the isocyanate is added dropwise to the mixture of polyether/polyester polyol and neopentyl glycol, and then the reaction is carried out to control the dropping speed. The dropping time is 1-2h, such as 1h, 1.2h, 1.4, 1.6h, 1.8h, 2h, etc.
在一些实施方式中,第一反应物与丙烯酸-2-羟乙酯、甲基丙烯酸羟乙酯混合后的反应温度为50-90℃,如50℃、60℃、70℃、80℃、90℃等。在实际操作中,将烯酸-2-羟乙酯、甲基丙烯酸羟乙酯滴加到第一反应物中,控制在10-20min内滴加完。反应过程中,每隔一定时间(例如1h)测定体系的红外光谱,当2236cm -1处-NCO的伸缩振动峰消失时,表明-NCO反应完全,即得到低雾度高韧性的聚氨酯丙烯酸酯。 In some embodiments, the reaction temperature after the first reactant is mixed with 2-hydroxyethyl acrylate and hydroxyethyl methacrylate is 50-90°C, such as 50°C, 60°C, 70°C, 80°C, 90°C ℃ and so on. In actual operation, 2-hydroxyethyl enoate and hydroxyethyl methacrylate are added dropwise to the first reactant, and the dropwise addition is controlled within 10-20 minutes. During the reaction process, the infrared spectrum of the system was measured at regular intervals (for example, 1 h). When the stretching vibration peak of -NCO at 2236 cm -1 disappeared, it indicated that the -NCO reaction was complete, and a polyurethane acrylate with low haze and high toughness was obtained.
本申请的第三方面是提供一种光固化材料,光固化材料的制备原料包括上述聚氨酯丙烯酸酯。The third aspect of the present application is to provide a photocurable material, and the raw material for preparing the photocurable material includes the above-mentioned urethane acrylate.
在一些实施方式中,光固化材料的制备原料还包括丙烯酸酯单体。丙烯酸酯单体在光照条件下可进行交联固化。In some embodiments, the raw materials for preparing the photocurable material further include acrylate monomers. Acrylate monomers can be cross-linked and cured under light conditions.
在一些实施方式中,丙烯酸酯单体包括单官能自由基丙烯酸酯单体和双官能自由基丙烯酸酯单体。In some embodiments, the acrylate monomers include monofunctional free radical acrylate monomers and difunctional free radical acrylate monomers.
在一些实施方式中,单官能自由基丙烯酸酯单体包括4-丙烯酰吗啉(ACMO)、甲基丙烯酸羟乙酯(HEMA)、丙烯酸-2-羟乙酯(HEA)、丙烯酸异冰片酯(IBOA)中的至少一种;双官能自由基丙烯酸酯单体包括三环癸烷二甲醇二丙烯酸酯(DCPDA)。In some embodiments, monofunctional free radical acrylate monomers include 4-acryloylmorpholine (ACMO), hydroxyethyl methacrylate (HEMA), 2-hydroxyethyl acrylate (HEA), isobornyl acrylate (IBOA); the difunctional free radical acrylate monomer includes tricyclodecane dimethanol diacrylate (DCPDA).
在一些实施方式中,单官能自由基丙烯酸酯单体和双官能自由基丙烯酸酯单体的质量比为1∶0.5-2,如1∶0.5、1∶1、1∶1.5、1∶2等。In some embodiments, the mass ratio of the monofunctional free radical acrylate monomer to the difunctional free radical acrylate monomer is 1:0.5-2, such as 1:0.5, 1:1, 1:1.5, 1:2, etc. .
在一些实施方式中,光固化材料的制备原料还包括生物基聚氨酯丙烯酸酯,该生物基聚氨酯丙烯酸酯具有如下结构式:In some embodiments, the raw materials for the preparation of photocurable materials also include bio-based urethane acrylate, and the bio-based urethane acrylate has the following structural formula:
Figure PCTCN2022130021-appb-000013
Figure PCTCN2022130021-appb-000013
其中,R 3
Figure PCTCN2022130021-appb-000014
x、y分别独立地选自1-100的整数。
Among them, R3 is
Figure PCTCN2022130021-appb-000014
x and y are each independently selected from an integer of 1-100.
需要说明的是,生物基聚氨酯丙烯酸酯含有聚乳酸(聚丙交酯)二醇和聚氧化丙烯二醇(PPG)链段,赋予生物基聚氨酯丙烯酸酯更高的硬度和耐磨性能,同时具备更高的水解稳定性,以及极佳的医用安全性。It should be noted that bio-based urethane acrylate contains polylactic acid (polylactide) diol and polyoxypropylene glycol (PPG) chain segments, which endow bio-based urethane acrylate with higher hardness and wear resistance, and at the same time have higher Excellent hydrolytic stability and excellent medical safety.
在一些实施方式中,生物基聚氨酯丙烯酸酯至少由如下原料聚合得到:聚丙交酯二醇、聚氧化丙烯二醇、脂肪族多异氰酸酯、甲基丙烯酸羟乙酯(HEMA)。In some embodiments, the bio-based urethane acrylate is polymerized from at least the following raw materials: polylactide diol, polyoxypropylene diol, aliphatic polyisocyanate, and hydroxyethyl methacrylate (HEMA).
在一些实施方式中,脂肪族多异氰酸酯包括五亚甲基二异氰酸酯(PDI)。五亚甲基二异氰酸酯(PDI)一般采用戊二胺(PDA)制成,生产过程可采用新型气相法技术,与传统工艺相比,采用该技术大大降低了能耗和溶剂使用量。PDA则是采用生物技术(具体来说是发酵工艺),通过生物质生产PDA成品。因此,合成PDI仅需两步,五亚甲基二异氰酸酯(PDI)中70%碳含量是来源于生物基可再生资源,因此具有高的生物质含量,其性能也十分优异。In some embodiments, the aliphatic polyisocyanate includes pentamethylene diisocyanate (PDI). Pentamethylene diisocyanate (PDI) is generally made of pentamethylenediamine (PDA). The production process can adopt a new gas phase method technology. Compared with the traditional process, this technology greatly reduces energy consumption and solvent usage. PDA uses biotechnology (specifically, fermentation process) to produce PDA finished products through biomass. Therefore, only two steps are needed to synthesize PDI, and 70% of the carbon content in pentamethylene diisocyanate (PDI) is derived from bio-based renewable resources, so it has a high biomass content and its performance is also very good.
在一些实施方式中,聚丙交酯二醇的分子量为1000-2000,如1000、1100、1300、1500、1600、1800、2000等。In some embodiments, the polylactide diol has a molecular weight of 1000-2000, such as 1000, 1100, 1300, 1500, 1600, 1800, 2000, etc.
在一些实施方式中,聚氧化丙烯二醇的分子量为300-500,如300、350、400、450、500等。In some embodiments, the polyoxypropylene diol has a molecular weight of 300-500, such as 300, 350, 400, 450, 500, etc.
在一些实施方式中,聚丙交酯二醇与聚氧化丙烯二醇的摩尔比为1∶0.5-2,如1∶0.5、1∶1.5、1∶1.7、1∶2、1∶1等。In some embodiments, the molar ratio of polylactide diol to polyoxypropylene diol is 1:0.5-2, such as 1:0.5, 1:1.5, 1:1.7, 1:2, 1:1, etc.
在一些实施方式中,聚丙交酯二醇、聚氧化丙烯二醇的总-OH与脂肪族多异氰酸酯的-NCO的摩尔比为1∶1-2,如1∶1、1∶1.5、1∶2等。In some embodiments, the molar ratio of the total -OH of polylactide diol and polyoxypropylene diol to the -NCO of aliphatic polyisocyanate is 1:1-2, such as 1:1, 1:1.5, 1:1 2 etc.
在一些实施方式中,聚丙交酯二醇、聚氧化丙烯二醇和甲基丙烯酸羟乙酯的总-OH与脂肪族多异氰酸酯的-NCO摩尔数相等。In some embodiments, the total -OH of polylactide diol, polyoxypropylene diol, and hydroxyethyl methacrylate is equal to the number of moles of -NCO of aliphatic polyisocyanate.
在一些实施方式中,生物基聚氨酯丙烯酸酯的制备方法为:使聚丙交酯二醇、聚氧化丙烯二醇、脂肪族多异氰酸酯、甲基丙烯酸羟乙酯进行聚合反应,得到生物基聚氨酯丙烯酸酯。In some embodiments, the preparation method of bio-based urethane acrylate is: polylactide diol, polyoxypropylene diol, aliphatic polyisocyanate, and hydroxyethyl methacrylate are polymerized to obtain bio-based urethane acrylate .
更具体地,生物基聚氨酯丙烯酸酯的制备方法可包括如下步骤:使聚丙交酯二醇、 聚氧化丙烯二醇和脂肪族多异氰酸酯进行聚合反应,反应至体系中无-OH残留;加入甲基丙烯酸羟乙酯,反应至体系中无-NCO残留,得到生物基聚氨酯丙烯酸酯。More specifically, the preparation method of bio-based urethane acrylate may include the following steps: polymerize polylactide diol, polyoxypropylene diol and aliphatic polyisocyanate until no -OH remains in the system; add methacrylic acid Hydroxyethyl ester, react until there is no -NCO residue in the system, to obtain bio-based polyurethane acrylate.
在一些实施方式中,上述聚丙交酯二醇、聚氧化丙烯二醇和脂肪族多异氰酸酯的反应温度为30-70℃,如30℃、40℃、50℃、60℃、70℃等。在实际操作中,将脂肪族多异氰酸酯滴加到聚丙交酯二醇、聚氧化丙烯二醇的混合物中,控制滴加速度,滴加时长为1-2h,如1h、1.2h、1.4h、1.6h、1.8h、2h等。In some embodiments, the reaction temperature of the polylactide diol, polyoxypropylene diol and aliphatic polyisocyanate is 30-70°C, such as 30°C, 40°C, 50°C, 60°C, 70°C, etc. In actual operation, the aliphatic polyisocyanate is added dropwise to the mixture of polylactide diol and polyoxypropylene diol, and the dropping speed is controlled, and the dropping time is 1-2h, such as 1h, 1.2h, 1.4h, 1.6 h, 1.8h, 2h, etc.
在一些实施方式中,加入甲基丙烯酸羟乙酯的反应温度为50-90℃,如50℃、60℃、70℃、80℃、90℃等。在实际操作中,将加入甲基丙烯酸羟乙酯滴加到反应体系中,控制在10-20min内滴加完。反应过程中,每隔一定时间(例如1h)测定体系的红外光谱,当2236cm -1处-NCO的伸缩振动峰消失时,表明-NCO反应完全,即得到生物基聚氨酯丙烯酸酯。 In some embodiments, the reaction temperature of adding hydroxyethyl methacrylate is 50-90°C, such as 50°C, 60°C, 70°C, 80°C, 90°C, etc. In actual operation, the hydroxyethyl methacrylate is added dropwise to the reaction system, and the dropwise addition is controlled within 10-20 minutes. During the reaction process, the infrared spectrum of the system was measured at regular intervals (for example, 1 h). When the stretching vibration peak of -NCO at 2236 cm -1 disappeared, it indicated that the -NCO reaction was complete, and the bio-based urethane acrylate was obtained.
在一些实施方式中,光固化材料的制备原料还包括高强度脂肪族聚氨酯丙烯酸酯,高强度脂肪族聚氨酯丙烯酸酯指的是完全固化后弯曲强度不低于90MPa的脂肪族聚氨酯丙烯酸酯,例如沙多玛的CN983NS、长兴的6164、6145-100等。In some embodiments, the raw materials for preparing the photocurable material also include high-strength aliphatic urethane acrylate, and high-strength aliphatic urethane acrylate refers to an aliphatic urethane acrylate with a bending strength of not less than 90 MPa after complete curing, such as sand Doma's CN983NS, Changxing's 6164, 6145-100, etc.
在一些实施方式中,光固化材料的制备原料还包括光引发剂。光引发剂包括Omnirad 819[二(2,4,6-三甲基苯甲酰基)-苯基氧化膦]、Omnirad DETX(2,4-二乙基硫杂蒽酮)、Omnirad ITX(2-异丙基硫杂蒽酮)、Omnirad TPO(2,4,6-三甲基苯甲酰基-二苯基氧化膦)中的至少一种。In some embodiments, the raw materials for preparing the photocurable material further include a photoinitiator. Photoinitiators include Omnirad 819 [bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide], Omnirad DETX (2,4-diethylthioxanthone), Omnirad ITX (2- Isopropylthioxanthone), Omnirad TPO (2,4,6-trimethylbenzoyl-diphenylphosphine oxide).
在一些实施方式中,按质量份计,光固化材料包括10-30份聚氨酯丙烯酸酯(即前述的低雾度高韧性的聚氨酯丙烯酸酯)、10-30份生物基聚氨酯丙烯酸酯、10-30份高强度脂肪族聚氨酯丙烯酸酯、3-10份单官能自由基丙烯酸酯单体、3-10份双官能自由基丙烯酸酯单体、1-10份光引发剂。In some embodiments, in parts by mass, the photocurable material includes 10-30 parts of urethane acrylate (that is, the aforementioned low-haze and high-toughness urethane acrylate), 10-30 parts of bio-based urethane acrylate, 10-30 parts 1 part of high-strength aliphatic urethane acrylate, 3-10 parts of monofunctional free radical acrylate monomer, 3-10 parts of bifunctional free radical acrylate monomer, and 1-10 parts of photoinitiator.
在一些实施方式中,按质量份计,光固化材料包括25-30份聚氨酯丙烯酸酯(即前述的低雾度高韧性的聚氨酯丙烯酸酯)、20-25份生物基聚氨酯丙烯酸酯、20-25份高强度脂肪族聚氨酯丙烯酸酯、5-10份单官能自由基丙烯酸酯单体、5-10份双官能自由基丙烯酸酯单体、1-5份光引发剂。In some embodiments, in parts by mass, the photocurable material includes 25-30 parts of urethane acrylate (ie, the aforementioned low-haze and high-toughness urethane acrylate), 20-25 parts of bio-based urethane acrylate, 20-25 parts 1 part of high-strength aliphatic urethane acrylate, 5-10 parts of monofunctional free radical acrylate monomer, 5-10 parts of difunctional free radical acrylate monomer, and 1-5 parts of photoinitiator.
本申请的第四方面是提供光固化材料的制备方法,包括如下步骤:将所有制备原料混合,即得光固化材料。即,将低雾度高韧性的聚氨酯丙烯酸酯、生物基聚氨酯丙烯酸酯、高强度脂肪族聚氨酯丙烯酸酯、单官能自由基丙烯酸酯单体、双官能自由基 丙烯酸酯单体和光引发剂混合,即得光固化材料。The fourth aspect of the present application is to provide a method for preparing a photocurable material, which includes the following steps: mixing all preparation raw materials to obtain a photocurable material. That is, low haze and high toughness urethane acrylate, bio-based urethane acrylate, high-strength aliphatic urethane acrylate, monofunctional free radical acrylate monomer, difunctional free radical acrylate monomer and photoinitiator are mixed, namely A photocurable material is obtained.
在一些实施方式中,需要先制备上述各种原料,然后将制备原料混合即可。其中,低雾度高韧性的聚氨酯丙烯酸酯、生物基聚氨酯丙烯酸酯的制备方法与前述各实施方式中的相似,相关详细内容请参阅前述各实施方式,此处不再赘述。In some embodiments, it is necessary to prepare the above-mentioned various raw materials first, and then mix the prepared raw materials. Among them, the preparation methods of low-haze and high-toughness urethane acrylate and bio-based urethane acrylate are similar to those in the above-mentioned embodiments. For related details, please refer to the above-mentioned embodiments, and will not be repeated here.
本申请的第五方面是提供光固化材料在制作口腔医疗器械中的应用。口腔医疗器械包括牙齿模型、咬合夹板、手术导板、保持器、正畸矫治器、牙套等。The fifth aspect of the present application is to provide the application of photocurable materials in making oral medical devices. Dental medical devices include tooth models, occlusal splints, surgical guides, retainers, orthodontic appliances, braces, etc.
本申请还提供一种口腔医疗器械的制作方法,包括如下步骤:以光固化材料为原料,在成型过程中进行光固化,得到口腔医疗器械。The present application also provides a method for manufacturing an oral medical device, which includes the following steps: taking a photocurable material as a raw material, and performing photocuring in a molding process to obtain a dental medical device.
在一些实施方式中,成型的方法包括3D打印。3D打印过程中的温度为30-40℃,例如35-38℃,湿度为35%-55%,如35%、40%、45%、50%、55%等。由于光固化材料中含有较多大分子的树脂,小分子物质较少,因此在3D打印过程中需要特殊的打印工艺。通过对3D打印的条件进行控制,从而达到降低打印材料粘度的效果,提高打印精度,降低工件层纹,提高细节分辨率,提高打印成型工件的整体稳定性。In some embodiments, the method of shaping includes 3D printing. The temperature during the 3D printing process is 30-40°C, such as 35-38°C, and the humidity is 35%-55%, such as 35%, 40%, 45%, 50%, 55%, etc. Since the light-curing material contains more macromolecular resins and less small molecular substances, a special printing process is required during the 3D printing process. By controlling the conditions of 3D printing, the effect of reducing the viscosity of the printing material can be achieved, the printing accuracy can be improved, the layer pattern of the workpiece can be reduced, the detail resolution can be improved, and the overall stability of the printed workpiece can be improved.
在实际操作中,3D打印过程可采用如下具体的操作:打印过程中,DLP打印机开启内部抽湿机,DLP打印机开启37℃热风机内部热风循环,DLP打印机使用料盘加热辅助功能。In actual operation, the 3D printing process can adopt the following specific operations: During the printing process, the DLP printer turns on the internal dehumidifier, the DLP printer turns on the internal hot air circulation of the 37°C hot air fan, and the DLP printer uses the tray heating auxiliary function.
在一些实施方式中,光固化过程采用的光源波长为385-405nm,如385nm、390nm、395nm、400nm、405nm等;在光固化后还可包括二次固化的步骤,二次固化处理的方法为在光固化后的样品的表面涂覆甘油,或者将光固化后的样品浸泡在甘油中。通过二次固化提高二次固化过程中的稳定性,保证整个打印过程中的整体性能的稳定性,从而为长期在患者口腔中的后续使用作保障。当然,在二次固化中,也可以不涂覆甘油,而直接浸入水等介质中进行固化,此处不做限定。In some embodiments, the wavelength of the light source used in the photocuring process is 385-405nm, such as 385nm, 390nm, 395nm, 400nm, 405nm, etc.; after photocuring, the step of secondary curing can also be included, and the method of secondary curing treatment is Coat glycerin on the surface of the photocured sample, or soak the photocured sample in glycerin. The stability in the secondary curing process is improved through secondary curing, ensuring the stability of the overall performance during the entire printing process, thus guaranteeing the long-term follow-up use in the patient's oral cavity. Of course, in the secondary curing, glycerin may not be applied, but directly immersed in water and other media for curing, which is not limited here.
本申请通过在聚氨酯丙烯酸酯中引入特殊结构的聚醚/聚酯多元醇软段,使得聚氨酯丙烯酸酯具有低雾度、高透过率、高韧性的特点,结合生物基聚氨酯丙烯酸酯、高强度脂肪族聚氨酯丙烯酸酯、单官能自由基丙烯酸酯单体、双官能自由基丙烯酸酯单体共同作用,使得光固化材料在固化后具有很合适的交联密度,力学强度佳、尺寸稳定性好、耐老化优异,雾度低、透过率高。This application introduces a special structure polyether/polyester polyol soft segment into polyurethane acrylate, so that polyurethane acrylate has the characteristics of low haze, high transmittance and high toughness, combined with bio-based polyurethane acrylate, high strength Aliphatic urethane acrylate, monofunctional free radical acrylate monomer, and bifunctional free radical acrylate monomer work together to make the photocurable material have a very suitable crosslinking density after curing, good mechanical strength, good dimensional stability, Excellent aging resistance, low haze and high transmittance.
一种光固化材料,所包括的组分如下表1和表2所示:A light-curing material, the components included are shown in Table 1 and Table 2 below:
表1光固化材料的原料组成(单位:质量份)The raw material composition of table 1 photocurable material (unit: mass part)
Figure PCTCN2022130021-appb-000015
Figure PCTCN2022130021-appb-000015
表2光固化材料的原料组成(单位:质量份)The raw material composition of table 2 photocurable material (unit: mass part)
Figure PCTCN2022130021-appb-000016
Figure PCTCN2022130021-appb-000016
Figure PCTCN2022130021-appb-000017
Figure PCTCN2022130021-appb-000017
表1和表2中的各原料为:Each raw material in table 1 and table 2 is:
(一)低雾度高韧性聚氨酯丙烯酸酯(1) Low haze and high toughness polyurethane acrylate
低雾度高韧性聚氨酯丙烯酸酯的ASTM雾度小于10,透过率大于85,具体合成方法为:The ASTM haze of low-haze and high-toughness urethane acrylate is less than 10, and the transmittance is greater than 85. The specific synthesis method is:
(1)确定反应条件:摩尔比n(醇):n(酸)为1.71,酸系催化剂质量分数为0.2%(以羧酸质量计),己二酸、对苯二甲酸和邻苯二甲酸的摩尔比例为1∶1∶1;聚氧化丙烯二醇和一缩二乙二醇的摩尔比例为1∶1。(1) Determine the reaction conditions: molar ratio n (alcohol): n (acid) is 1.71, and the mass fraction of acid catalyst is 0.2% (in terms of carboxylic acid mass), adipic acid, terephthalic acid and phthalic acid The molar ratio of polyoxypropylene diol and diethylene glycol is 1:1.
将己二酸、对苯二甲酸、邻苯二甲酸、聚氧化丙烯二醇和一缩二乙二醇加入反应釜,在100℃下无规共聚酯化反应4h,而后在1h内升温至200℃并开始抽真空,并加入酸系催化剂,在200℃真空度为0.09MPa下反应4h后,进行酸值的测定,待酸值小于1.0mgKOH/g后停止反应,得到粘稠透明的主链相对无规的聚醚/聚酯多元醇软段结构。Add adipic acid, terephthalic acid, phthalic acid, polyoxypropylene glycol and diethylene glycol into the reactor, conduct random copolyesterification at 100°C for 4 hours, and then raise the temperature to 200°C within 1 hour ℃ and start vacuuming, and add an acid catalyst, react at 200 ℃ for 4 hours under a vacuum of 0.09MPa, then measure the acid value, stop the reaction when the acid value is less than 1.0mgKOH/g, and obtain a viscous and transparent main chain Relatively random polyether/polyester polyol soft segment structure.
(2)控制n(-OH)∶n(-NCO)为1∶1.5,主链相对无规的聚醚/聚酯多元醇和NPG的摩尔比例为1∶1,先将主链相对无规的聚醚/聚酯多元醇和NPG加入反应釜,然后滴加IPDI,其中IPDI选自FDA认证的可用于食品接触应用的食品级IPDI固化剂。控制IPDI的滴加速度,滴加时长为2h,反应温度控制在60℃,反应完全后,体系的-OH已无残留,剩余未反应基团-NCO。(2) Control n(-OH):n(-NCO) to be 1:1.5, the molar ratio of the main chain relatively random polyether/polyester polyol and NPG is 1:1, and the main chain is relatively random Polyether/polyester polyol and NPG are added to the reactor, and then IPDI is added dropwise, where IPDI is selected from FDA-approved food-grade IPDI curing agents that can be used in food contact applications. Control the IPDI drop rate, the drop time is 2h, and the reaction temperature is controlled at 60°C. After the reaction is complete, there is no residual -OH in the system, and the remaining unreacted groups -NCO.
再控制n(-OH)∶n(-NCO)为1∶1,将HEA和HEMA滴加到体系中进一步反应,反应温度控制在60℃,20min滴加完成,每隔1h测定体系的红外光谱,当2236cm -1处-NCO的伸缩振动峰消失时,表明-NCO反应完全,即得到产物低雾度高韧性聚氨酯丙烯酸酯。 Then control the ratio of n(-OH):n(-NCO) to 1:1, add HEA and HEMA dropwise into the system for further reaction, control the reaction temperature at 60°C, complete the dropwise addition in 20 minutes, measure the infrared spectrum of the system every 1h , when the stretching vibration peak of -NCO at 2236cm -1 disappears, it indicates that the -NCO reaction is complete, and the product low haze and high toughness polyurethane acrylate is obtained.
(二)生物基聚氨酯丙烯酸酯(2) Bio-based polyurethane acrylate
生物基聚氨酯丙烯酸酯由分子量1000-2000的聚丙交酯二醇和分子量400的聚氧化丙烯二醇(PPG),HEMA,PDI经本体聚合工艺得到,具体合成方法为:Bio-based urethane acrylate is obtained from polylactide diol with a molecular weight of 1000-2000 and polyoxypropylene diol (PPG) with a molecular weight of 400, HEMA, and PDI through bulk polymerization. The specific synthesis method is as follows:
(1)控制n(-OH)∶n(-NCO)为1∶1.5,聚丙交酯二醇和PPG的摩尔比例为1∶1, 先将聚丙交酯二醇和PPG加入反应釜,然后滴加PDI,控制滴加速度,滴加时长为2h,反应温度控制在50℃,反应完全后,体系的-OH已无残留,剩余未反应基团-NCO。(1) Control n(-OH):n(-NCO) to be 1:1.5, the molar ratio of polylactide diol and PPG to be 1:1, first add polylactide diol and PPG to the reactor, and then add PDI dropwise , control the dropping speed, the dropping time is 2h, and the reaction temperature is controlled at 50°C. After the reaction is complete, there is no remaining -OH in the system, and the remaining unreacted groups -NCO.
(2)再控制n(-OH)∶n(-NCO)为1∶1,将HEMA滴加到体系中进一步反应,反应温度控制在70℃,20min滴加完成,每隔1h测定体系的红外光谱,当2236cm -1处-NCO的伸缩振动峰消失时,表明-NCO反应完全,即得到产物生物基聚氨酯丙烯酸酯。 (2) Then control the ratio of n(-OH):n(-NCO) to 1:1, add HEMA dropwise into the system for further reaction, control the reaction temperature at 70°C, complete the dropwise addition in 20 minutes, measure the infrared of the system every 1h Spectrum, when the stretching vibration peak of -NCO at 2236cm -1 disappears, it shows that the reaction of -NCO is complete, and the product bio-based urethane acrylate is obtained.
(三)高强度脂肪族聚氨酯丙烯酸酯(3) High-strength aliphatic urethane acrylate
高强度脂肪族聚氨酯丙烯酸酯为购自沙多玛的完全固化后弯曲强度不低于90MPA的高强度脂肪族聚氨酯丙烯酸酯(沙多玛的CN983NS)。The high-strength aliphatic urethane acrylate is a high-strength aliphatic urethane acrylate (CN983NS of Sartomer) with a flexural strength of not less than 90MPA after complete curing purchased from Sartomer.
单官能团丙烯酸酯是丙烯酰吗啉(ACMO)。A monofunctional acrylate is acryloylmorpholine (ACMO).
双官能团丙烯酸酯是三环癸烷二甲醇二丙烯酸酯(DCPDA)。The difunctional acrylate is tricyclodecane dimethanol diacrylate (DCPDA).
以上述实施例1和对比例1-10的光固化材料为原料,采用DLP 3D打印机打印成种植手术用导板成品。打印过程中,DLP打印机开启内部抽湿机(湿度控制在35%-55%),DLP打印机开启37℃热风机内部热风循环,DLP打印机使用料盘加热辅助功能,从而达到降低打印材料粘度的效果,提高打印精度,降低工件层纹,提高细节分辨率,提高打印成型工件的整体稳定性。后处理工艺:后固化采用在385nm波段光源下的固化箱,并且在医用甘油下进行后处理二次固化,提高二次固化过程中的稳定性,保证整个打印过程中的整体性能的稳定性,从而为长期在患者口腔中的后续使用作保障。Using the light-cured materials of the above-mentioned Example 1 and Comparative Examples 1-10 as raw materials, a DLP 3D printer was used to print a finished guide plate for implant surgery. During the printing process, the DLP printer turns on the internal dehumidifier (humidity is controlled at 35%-55%), the DLP printer turns on the internal hot air circulation of the 37°C hot air fan, and the DLP printer uses the heating auxiliary function of the tray to achieve the effect of reducing the viscosity of the printing material , improve the printing accuracy, reduce the layer pattern of the workpiece, improve the detail resolution, and improve the overall stability of the printed workpiece. Post-processing process: Post-curing adopts a curing box under the 385nm band light source, and performs post-processing secondary curing under medical glycerin to improve the stability of the secondary curing process and ensure the stability of the overall performance during the entire printing process. Thereby guaranteeing the follow-up use in the patient's oral cavity for a long time.
(1)常规性能检测(1) Routine performance testing
对打印得到的成品进行常规性能检测,同时以市售成品【Graphy竞品,成品牌号为Tera Harz TC-85,TC-85DAC(透明)】进行比较,结果如下表所示。Routine performance testing was carried out on the printed finished product, and at the same time a comparison was made with the commercially available finished product [Graphy competitor product, brand name Tera Harz TC-85, TC-85DAC (transparent)]. The results are shown in the table below.
表3性能枪测结果Table 3 Performance gun test results
Figure PCTCN2022130021-appb-000018
Figure PCTCN2022130021-appb-000018
Figure PCTCN2022130021-appb-000019
Figure PCTCN2022130021-appb-000019
表4性能检测结果Table 4 performance test results
Figure PCTCN2022130021-appb-000020
Figure PCTCN2022130021-appb-000020
其中,酒精浸泡尺寸稳定性和碘伏浸泡尺寸稳定性的测试方法为,使成品在酒精或碘伏中浸泡30min,然后检测成品的尺寸公差。Among them, the test method for the dimensional stability of alcohol immersion and iodophor immersion is to soak the finished product in alcohol or iodophor for 30 minutes, and then detect the dimensional tolerance of the finished product.
在人工唾液(ISO/TR10271,酸性)对打印得到的成品进行加速浸泡720小时,然后检测其性能,如下表5和6所示。The printed finished product was accelerated soaking in artificial saliva (ISO/TR10271, acidic) for 720 hours, and then its performance was tested, as shown in Tables 5 and 6 below.
表5人工唾液(ISO/TR10271,酸性)加速浸泡720小时后的性能检测结果Table 5 Performance test results of artificial saliva (ISO/TR10271, acidic) accelerated immersion for 720 hours
Figure PCTCN2022130021-appb-000021
Figure PCTCN2022130021-appb-000021
Figure PCTCN2022130021-appb-000022
Figure PCTCN2022130021-appb-000022
表6.人工唾液(ISO/TR10271,酸性)加速浸泡720小时后的性能检测结果Table 6. Performance test results after accelerated immersion in artificial saliva (ISO/TR10271, acidic) for 720 hours
Figure PCTCN2022130021-appb-000023
Figure PCTCN2022130021-appb-000023
在人工唾液(ISO/TR10271,中性无菌)对打印得到的成品进行加速浸泡720小时,然后检测其性能,如下表7和8所示。The printed finished product was soaked in artificial saliva (ISO/TR10271, neutral aseptic) for 720 hours at an accelerated rate, and then its performance was tested, as shown in Tables 7 and 8 below.
表7人工唾液(ISO/TR10271,中性无菌)加速浸泡720小时后的性能检测结果Table 7 Performance test results of artificial saliva (ISO/TR10271, neutral aseptic) accelerated immersion for 720 hours
Figure PCTCN2022130021-appb-000024
Figure PCTCN2022130021-appb-000024
表8人工唾液(ISO/TR10271,中性无菌)加速浸泡720小时后的性能检测结果Table 8 Performance test results of artificial saliva (ISO/TR10271, neutral aseptic) accelerated immersion for 720 hours
Figure PCTCN2022130021-appb-000025
Figure PCTCN2022130021-appb-000025
将打印得到的成品在37℃,80%湿度放置1440小时,然后检测其性能,如下表9 和10所示。The printed finished product was placed at 37° C. and 80% humidity for 1440 hours, and then its performance was tested, as shown in Tables 9 and 10 below.
表9 37℃,80%湿度放置1440小时后的性能检测结果Table 9 Performance test results after 1440 hours at 37°C and 80% humidity
Figure PCTCN2022130021-appb-000026
Figure PCTCN2022130021-appb-000026
表10 37℃,80%湿度放置1440小时后的性能检测结果Table 10 Performance test results after 1440 hours at 37°C and 80% humidity
Figure PCTCN2022130021-appb-000027
Figure PCTCN2022130021-appb-000027
测试结果显示:The test results show:
实施例1的光固化材料的3D打印成品具有良好的力学性能,雾度低,透过率高,尺寸稳定性好,耐老化性能优异,综合性能较市售成品明显提高。而对比例1不加双官能团丙烯酸酯,交联密度偏低,反应偏慢,整体固化不充分,力学性能强度偏低,尺寸稳定性差。对比例2不加单官能团丙烯酸酯,雾度偏高,透过率偏低,韧性变差;对比例3提高低雾度高韧性聚氨酯丙烯酸酯的量,整体反应偏慢,强度偏低,尺寸稳定性,耐老化性能差;对比例4降低低雾度高韧性聚氨酯丙烯酸酯的量,雾度上升,透过率偏低;对比例5提高生物基聚氨酯丙烯酸酯的量,整体强度偏高,韧性下降,雾度上升,透过率下降;对比例6降低生物基聚氨酯丙烯酸酯的量,整体强度偏低,耐老化性能变差,尺寸稳定性变差;对比例7提高高强度脂肪族聚氨酯丙烯酸酯的量,强度上升,韧性下降,雾度上升,透过率偏低;对比例8降低高强度脂肪族聚氨酯丙烯酸酯的量,力学性能下降,尺寸稳定性变差;对比例9不加入低雾度高韧性脂肪族聚氨酯丙烯酸酯,雾度大幅度上升。透过率大幅度下降;对比例10:不加入生物基聚 氨酯丙烯酸酯,尺寸稳定性变差,耐老化能力变差。The 3D printed finished product of the light-cured material in Example 1 has good mechanical properties, low haze, high transmittance, good dimensional stability, excellent aging resistance, and the overall performance is significantly improved compared with the commercially available finished product. In comparison example 1, without the addition of difunctional acrylate, the crosslinking density is low, the reaction is slow, the overall curing is insufficient, the strength of mechanical properties is low, and the dimensional stability is poor. Comparative example 2 does not add monofunctional acrylate, the haze is high, the transmittance is low, and the toughness is poor; in comparative example 3, the amount of polyurethane acrylate with low haze and high toughness is increased, the overall reaction is slow, the strength is low, and the size Stability and aging resistance are poor; comparative example 4 reduces the amount of low-haze and high-toughness polyurethane acrylate, the haze increases, and the transmittance is low; comparative example 5 increases the amount of bio-based polyurethane acrylate, the overall strength is high, The toughness decreased, the haze increased, and the transmittance decreased; in comparative example 6, the amount of bio-based polyurethane acrylate was reduced, the overall strength was low, the aging resistance was deteriorated, and the dimensional stability was deteriorated; comparative example 7 increased the high-strength aliphatic polyurethane The amount of acrylate increases, the strength increases, the toughness decreases, the haze increases, and the transmittance is low; in comparative example 8, the amount of high-strength aliphatic urethane acrylate is reduced, the mechanical properties decrease, and the dimensional stability deteriorates; comparative example 9 does not add Low haze and high toughness aliphatic urethane acrylate, the haze is greatly increased. The transmittance decreased significantly; Comparative Example 10: No bio-based polyurethane acrylate was added, the dimensional stability deteriorated, and the aging resistance deteriorated.
(2)成品/导环匹配性(2) Compatibility of finished product/guide ring
如图1所示,将实施例1的导板成品与导环进行匹配,结果显示导板就位良好,与牙齿模型贴合良好,无翘动、摆动、松紧度适中;从观察窗观测,导板与牙齿密贴,松紧度合适,套环与导环孔平台齐平,佩戴良好。As shown in Figure 1, the finished guide plate of Example 1 was matched with the guide ring, and the results showed that the guide plate was in place well, fit well with the tooth model, without warping, swinging, and moderate tightness; observed from the observation window, the guide plate and The teeth fit tightly, the tightness is suitable, the collar is flush with the platform of the guide ring hole, and it fits well.
(3)生物相容性测试(3) Biocompatibility test
对实施例1的光固化材料打印后的成品进行生物相容性测试,结果如下表所示:The biocompatibility test was carried out on the printed finished product of the light-curing material of Example 1, and the results are shown in the table below:
表11Table 11
Figure PCTCN2022130021-appb-000028
Figure PCTCN2022130021-appb-000028
根据YY/T 0127.9-2009《口腔医疗器械生物学评价第2单元:试验方法细胞毒性试验:琼脂扩散法及滤膜扩散法》中推荐的方法对实施例1的光固化材料打印后的成品进行体外毒性试验,根据GB/T16886.10-2017《医疗器械生物学评价第10部分:刺激与皮肤致敏试验》的最大剂量法进行豚鼠迟发型超敏反应的潜在性试验,采用GB/T16886.10-2017《医疗器械生物学评价第10部分:刺激与皮肤致敏试验》推荐的方法进行口腔黏膜刺激试验,结果如表12所示:According to the method recommended in YY/T 0127.9-2009 "Biological Evaluation of Dental Medical Devices Unit 2: Test Method Cytotoxicity Test: Agar Diffusion Method and Membrane Diffusion Method", the finished product after printing the light-cured material of Example 1 was tested. In vitro toxicity test, according to the maximum dose method of GB/T16886.10-2017 "Biological Evaluation of Medical Devices Part 10: Irritation and Skin Sensitization Test", the potential test of delayed hypersensitivity in guinea pigs was carried out, using GB/T16886. 10-2017 "Medical Device Biological Evaluation Part 10: Irritation and Skin Sensitization Test" recommended method for oral mucosal irritation test, the results are shown in Table 12:
表12Table 12
Figure PCTCN2022130021-appb-000029
Figure PCTCN2022130021-appb-000029
测试结果显示,实施例1的光固化材料打印后的成品具有很好的生物相容性,细 胞毒性低,无致敏反应、无刺激性。The test results show that the finished product printed with the photocurable material of Example 1 has good biocompatibility, low cytotoxicity, no sensitization, and no irritation.
(4)其他法规、标准要求(4) Other regulations and standard requirements
另外,按照相关法规、标准要求,对实施例1的光固化材料在光固化前后(即聚合前后)的其他各项标准要求进行检测,结果如下表13所示:In addition, in accordance with relevant regulations and standard requirements, the photocurable material of Example 1 was tested for other standard requirements before and after photocuring (ie, before and after polymerization), and the results are shown in Table 13 below:
表13Table 13
Figure PCTCN2022130021-appb-000030
Figure PCTCN2022130021-appb-000030
Figure PCTCN2022130021-appb-000031
Figure PCTCN2022130021-appb-000031
Figure PCTCN2022130021-appb-000032
Figure PCTCN2022130021-appb-000032
上述结果显示,实施例1的光固化材料的性能符合各项法规、标准的要求。The above results show that the performance of the photocurable material in Example 1 meets the requirements of various regulations and standards.
上述实施例为本申请较佳的实施方式,但本申请的实施方式并不受上述实施例的限制,其他的任何未背离本申请的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本申请的保护范围之内。The above-mentioned embodiment is a preferred implementation mode of the application, but the implementation mode of the application is not limited by the above-mentioned embodiment, and any other changes, modifications, substitutions, combinations, Simplifications should be equivalent replacement methods, and all are included in the protection scope of the present application.

Claims (25)

  1. 一种聚氨酯丙烯酸酯,其特征在于,所述聚氨酯丙烯酸酯含有聚醚/聚酯多元醇的结构单元,所述聚醚/聚酯多元醇具有如下式I、式II、式III中的至少一种结构式:A kind of polyurethane acrylate, it is characterized in that, described polyurethane acrylate contains the structural unit of polyether/polyester polyol, and described polyether/polyester polyol has at least one in following formula I, formula II, formula III A structural formula:
    Figure PCTCN2022130021-appb-100001
    Figure PCTCN2022130021-appb-100001
    其中,n为1-1000的整数。Wherein, n is an integer of 1-1000.
  2. 根据权利要求1所述的聚氨酯丙烯酸酯,其特征在于,所述聚氨酯丙烯酸酯含有如下式IV所示的链段:The polyurethane acrylate according to claim 1, wherein the polyurethane acrylate contains a chain segment shown in the following formula IV:
    Figure PCTCN2022130021-appb-100002
    Figure PCTCN2022130021-appb-100002
    其中,R 0
    Figure PCTCN2022130021-appb-100003
    where R 0 is
    Figure PCTCN2022130021-appb-100003
    R 1、R 1’分别独立地选自
    Figure PCTCN2022130021-appb-100004
    所述R 1a、R 1b分别独立地选自H或 C 1-3烷基;
    R 1 , R 1 ' are independently selected from
    Figure PCTCN2022130021-appb-100004
    The R 1a and R 1b are independently selected from H or C 1-3 alkyl;
    R 2为所述聚醚/聚酯多元醇的结构单元。 R 2 is a structural unit of the polyether/polyester polyol.
  3. 根据权利要求2所述的聚氨酯丙烯酸酯,其特征在于,所述R 1、R 1’分别独立地选自
    Figure PCTCN2022130021-appb-100005
    The polyurethane acrylate according to claim 2, wherein said R 1 and R 1 ' are independently selected from
    Figure PCTCN2022130021-appb-100005
  4. 根据权利要求1至3中任一项所述的聚氨酯丙烯酸酯,其特征在于,所述聚氨酯丙烯酸酯满足ASTM雾度小于10%、透过率大于85%、缺口冲击强度大于60J/M中的至少一者。According to the polyurethane acrylate according to any one of claims 1 to 3, it is characterized in that the polyurethane acrylate meets the requirements of ASTM haze less than 10%, transmittance greater than 85%, and notched impact strength greater than 60J/M. at least one.
  5. 一种权利要求1至4中任一项所述聚氨酯丙烯酸酯的制备方法,其特征在于,所述制备方法包括如下步骤:使聚醚/聚酯多元醇与丙烯酸-2-羟乙酯、新戊二醇、甲基丙烯酸羟乙酯和异氰酸酯进行本体聚合,得到聚氨酯丙烯酸酯;A preparation method of polyurethane acrylate described in any one of claims 1 to 4, is characterized in that, described preparation method comprises the steps: make polyether/polyester polyol and acrylate-2-hydroxyethyl ester, new Pentylene glycol, hydroxyethyl methacrylate and isocyanate carry out bulk polymerization to obtain polyurethane acrylate;
    其中,所述聚醚/聚酯多元醇具有如下式I、式II、式III中的至少一种结构式:Wherein, the polyether/polyester polyol has at least one structural formula in the following formula I, formula II, and formula III:
    Figure PCTCN2022130021-appb-100006
    Figure PCTCN2022130021-appb-100006
    其中,n为1-1000的整数。Wherein, n is an integer of 1-1000.
  6. 根据权利要求5所述的制备方法,其特征在于,所述聚醚/聚酯多元醇由脂肪二元酸、芳香二元酸、聚氧化丙烯二醇与多元醇经过无规共聚得到。The preparation method according to claim 5, characterized in that the polyether/polyester polyol is obtained by random copolymerization of fatty dibasic acid, aromatic dibasic acid, polyoxypropylene diol and polyol.
  7. 根据权利要求6所述的制备方法,其特征在于,所述聚醚/聚酯多元醇的制备方法包括:preparation method according to claim 6, is characterized in that, the preparation method of described polyether/polyester polyol comprises:
    将脂肪二元酸、芳香二元酸、聚氧化丙烯二醇和多元醇混合,进行无规共聚酯化反应,得到无规共聚酯化产物;Mix aliphatic dibasic acid, aromatic dibasic acid, polyoxypropylene diol and polyol, and carry out random copolyesterification reaction to obtain random copolyesterification product;
    对所述无规共聚酯化产物进行酸催化处理,得到所述聚醚/聚酯多元醇;performing an acid-catalyzed treatment on the random copolyesterification product to obtain the polyether/polyester polyol;
    其中,所述无规共聚的温度为90-160℃,时间为2-4h;所述酸催化处理的反应温度为180-230℃,时间为1-4h,真空度为0.08-0.09MPa。Wherein, the temperature of the random copolymerization is 90-160°C, and the time is 2-4h; the reaction temperature of the acid-catalyzed treatment is 180-230°C, the time is 1-4h, and the vacuum degree is 0.08-0.09MPa.
  8. 根据权利要求6或7所述的制备方法,其特征在于,所述脂肪二元酸包括己二酸;所述芳香二元酸包括对苯二甲酸、邻苯二甲酸中的至少一种;所述聚氧化丙烯二醇的分子量为300-600;所述多元醇为一缩二乙二醇。The preparation method according to claim 6 or 7, wherein the fatty dibasic acid includes adipic acid; the aromatic dibasic acid includes at least one of terephthalic acid and phthalic acid; The molecular weight of the polyoxypropylene diol is 300-600; the polyol is diethylene glycol.
  9. 根据权利要求8所述的制备方法,其特征在于,所述聚氧化丙烯二醇和所述多元醇的总摩尔数为m1,所述脂肪二元酸和所述芳香二元酸的总摩尔数为m2,m1∶m2=1-2∶1;preparation method according to claim 8, is characterized in that, the total molar number of described polyoxypropylene diol and described polyvalent alcohol is m1, and the total molar number of described fatty dibasic acid and described aromatic dibasic acid is m2, m1:m2=1-2:1;
    所述脂肪二元酸与所述芳香二元酸的摩尔比为1∶1-3;The molar ratio of the fatty dibasic acid to the aromatic dibasic acid is 1:1-3;
    所述芳香二元酸为所述对苯二甲酸和所述邻苯二甲酸的组合,所述脂肪二元酸、所述对苯二甲酸和所述邻苯二甲酸的摩尔比为1∶0.5-1.5∶0.5-1.5;The aromatic dibasic acid is a combination of the terephthalic acid and the phthalic acid, and the molar ratio of the fatty dibasic acid, the terephthalic acid and the phthalic acid is 1:0.5 -1.5: 0.5-1.5;
    所述聚氧化丙烯二醇与所述多元醇的摩尔比为1∶0.5-1.5。The molar ratio of the polyoxypropylene diol to the polyol is 1:0.5-1.5.
  10. 根据权利要求5至9中任一项所述的制备方法,其特征在于,包括如下步骤:According to the preparation method described in any one of claims 5 to 9, it is characterized in that comprising the steps of:
    将所述聚醚/聚酯多元醇与所述新戊二醇、所述异氰酸酯混合并进行第一反应,反应至少体系无-OH残留,得到第一反应物;Mixing the polyether/polyester polyol with the neopentyl glycol and the isocyanate and performing a first reaction, at least no -OH remains in the reaction system to obtain a first reactant;
    将所述第一反应物与所述丙烯酸-2-羟乙酯、所述甲基丙烯酸羟乙酯混合并进行第二反应,反应至体系无-NCO残留,得到聚氨酯丙烯酸酯。The first reactant is mixed with the 2-hydroxyethyl acrylate and the hydroxyethyl methacrylate to perform a second reaction until no -NCO remains in the system to obtain urethane acrylate.
  11. 根据权利要求10所述的制备方法,其特征在于,在所述第一反应过程中,将所述异氰酸酯滴加到所述聚醚/聚酯多元醇与所述新戊二醇的混合物中,滴加时长为1-2h,所述第一反应的温度为30-70℃;The preparation method according to claim 10, wherein, in the first reaction process, the isocyanate is added dropwise to the mixture of the polyether/polyester polyol and the neopentyl glycol, The dropping time is 1-2h, and the temperature of the first reaction is 30-70°C;
    在第二反应过程中,将所述丙烯酸-2-羟乙酯与所述甲基丙烯酸羟乙酯滴加到所述第一反应物中,滴加时长为10-20min;所述第二反应的温度为50-90℃。During the second reaction, the 2-hydroxyethyl acrylate and the hydroxyethyl methacrylate are added dropwise to the first reactant for 10-20 minutes; the second reaction The temperature is 50-90°C.
  12. 根据权利要求10所述的制备方法,其特征在于,所述聚醚/聚酯多元醇与所述新戊二醇的总-OH与所述异氰酸酯中的-NCO的摩尔比为1∶0.5-2;The preparation method according to claim 10, characterized in that, the molar ratio of the total -OH of the polyether/polyester polyol and the neopentyl glycol to the -NCO in the isocyanate is 1: 0.5- 2;
    所述聚醚/聚酯多元醇与所述新戊二醇的摩尔比为1∶0.5-1.5;The molar ratio of the polyether/polyester polyol to the neopentyl glycol is 1:0.5-1.5;
    所述聚醚/聚酯多元醇、所述丙烯酸-2-羟乙酯、所述新戊二醇和所述甲基丙烯酸羟乙酯的总-OH与所述异氰酸酯中的-NCO摩尔数相等。The total -OH of the polyether/polyester polyol, the 2-hydroxyethyl acrylate, the neopentyl glycol and the hydroxyethyl methacrylate is equal to the number of moles of -NCO in the isocyanate.
  13. 一种光固化材料,其特征在于,所述光固化材料包括权利要求1-4中任一项所述的聚氨酯丙烯酸酯。A photocurable material, characterized in that the photocurable material comprises the polyurethane acrylate described in any one of claims 1-4.
  14. 根据权利要求13所述的光固化材料,其特征在于,所述光固化材料还包括丙烯酸酯单体;The light-curing material according to claim 13, wherein the light-curing material further comprises an acrylate monomer;
    其中,所述丙烯酸酯单体包括单官能自由基丙烯酸酯单体和双官能自由基丙烯酸酯单体;所述单官能自由基丙烯酸酯单体和所述双官能自由基丙烯酸酯单体的质量比为1∶0.5-2。Wherein, the acrylate monomer includes a monofunctional free radical acrylate monomer and a difunctional free radical acrylate monomer; the mass of the monofunctional free radical acrylate monomer and the difunctional free radical acrylate monomer The ratio is 1:0.5-2.
  15. 根据权利要求13或14所述的光固化材料,其特征在于,所述单官能自由基丙烯酸酯单体选自4-丙烯酰吗啉、甲基丙烯酸羟乙酯、丙烯酸-2-羟乙酯、丙烯酸异冰片酯中的任意一种或多种;所述双官能自由基丙烯酸酯单体为三环癸烷二甲醇二丙烯酸酯。The photocurable material according to claim 13 or 14, wherein the monofunctional radical acrylate monomer is selected from the group consisting of 4-acryloylmorpholine, hydroxyethyl methacrylate, and 2-hydroxyethyl acrylate , any one or more of isobornyl acrylate; the difunctional radical acrylate monomer is tricyclodecane dimethanol diacrylate.
  16. 根据权利要求13至15中任一项所述的光固化材料,其特征在于,所述光固化材料还包括生物基聚氨酯丙烯酸酯,所述生物基聚氨酯丙烯酸酯具有如下结构式:The photocurable material according to any one of claims 13 to 15, wherein the photocurable material further comprises bio-based urethane acrylate, and the bio-based urethane acrylate has the following structural formula:
    Figure PCTCN2022130021-appb-100007
    Figure PCTCN2022130021-appb-100007
    其中,R 3
    Figure PCTCN2022130021-appb-100008
    x、y分别独立地选自1-100的整数。
    Among them, R3 is
    Figure PCTCN2022130021-appb-100008
    x and y are each independently selected from an integer of 1-100.
  17. 根据权利要求13至16中任一项所述的光固化材料,其特征在于,所述光固化材料还包括高强度脂肪族聚氨酯丙烯酸酯,所述高强度脂肪族聚氨酯丙烯酸酯为完全固化后弯曲强度不低于90MPa的脂肪族聚氨酯丙烯酸酯。The light-curing material according to any one of claims 13 to 16, wherein the light-curing material also includes high-strength aliphatic urethane acrylate, and the high-strength aliphatic urethane acrylate is bent after complete curing. Aliphatic urethane acrylate with strength not lower than 90MPa.
  18. 根据权利要求13至17中任一项所述的光固化材料,其特征在于,所述光固化材料还包括光引发剂,所述光引发剂选自二(2,4,6-三甲基苯甲酰基)-苯基氧化膦、2,4-二乙基硫杂蒽酮、2-异丙基硫杂蒽酮、2,4,6-三甲基苯甲酰基-二苯基氧化膦中的任 意一种或多种。The photocurable material according to any one of claims 13 to 17, wherein the photocurable material also includes a photoinitiator selected from bis(2,4,6-trimethyl Benzoyl)-phenylphosphine oxide, 2,4-diethylthioxanthone, 2-isopropylthioxanthone, 2,4,6-trimethylbenzoyl-diphenylphosphine oxide any one or more of them.
  19. 根据权利要求13所述的光固化材料,其特征在于,按质量份计,所述光固化材料包括10-30份聚氨酯丙烯酸酯、10-30份生物基聚氨酯丙烯酸酯、10-30份高强度脂肪族聚氨酯丙烯酸酯、3-10份单官能自由基丙烯酸酯单体、3-10份双官能自由基丙烯酸酯单体、1-10份光引发剂。The light-curing material according to claim 13, wherein, in parts by mass, the light-curing material comprises 10-30 parts of polyurethane acrylate, 10-30 parts of bio-based polyurethane acrylate, 10-30 parts of high-strength Aliphatic urethane acrylate, 3-10 parts of monofunctional free radical acrylate monomer, 3-10 parts of difunctional free radical acrylate monomer, 1-10 parts of photoinitiator.
  20. 一种光固化材料的制备方法,其特征在于,所述光固化材料包括聚氨酯丙烯酸酯,所述制备方法包括权利要求5至12中任一项所述的聚氨酯丙烯酸酯的制备方法。A method for preparing a photocurable material, characterized in that the photocurable material includes polyurethane acrylate, and the preparation method includes the method for preparing polyurethane acrylate according to any one of claims 5 to 12.
  21. 根据权利要求20所述的制备方法,其特征在于,所述光固化材料还包括生物基聚氨酯丙烯酸酯,所述制备方法还包括:The preparation method according to claim 20, wherein the photocurable material also includes bio-based urethane acrylate, and the preparation method also includes:
    将所述聚丙交酯二醇、所述聚氧化丙烯二醇和所述脂肪族多异氰酸酯进行第三反应,反应至体系中无-OH残留,得到第三反应物;performing a third reaction on the polylactide diol, the polyoxypropylene diol and the aliphatic polyisocyanate until no -OH remains in the system to obtain a third reactant;
    向所述第三反应物中加入甲基丙烯酸羟乙酯进行第四反应,反应至体系中无-NCO残留,得到所述生物基聚氨酯丙烯酸酯。Adding hydroxyethyl methacrylate to the third reactant to carry out the fourth reaction until no -NCO remains in the system to obtain the bio-based urethane acrylate.
  22. 根据权利要求21所述的制备方法,其特征在于,所述第三反应的温度为30-70℃;所述第四反应的温度为50-90℃;The preparation method according to claim 21, characterized in that, the temperature of the third reaction is 30-70°C; the temperature of the fourth reaction is 50-90°C;
    所述脂肪族多异氰酸酯为五亚甲基二异氰酸酯;所述聚丙交酯二醇的分子量为1000-2000;所述聚氧化丙烯二醇的分子量为300-500;The aliphatic polyisocyanate is pentamethylene diisocyanate; the molecular weight of the polylactide diol is 1000-2000; the molecular weight of the polyoxypropylene diol is 300-500;
    所述聚丙交酯二醇与所述聚氧化丙烯二醇的摩尔比为1∶0.5-2;所述聚丙交酯二醇与所述聚氧化丙烯二醇的总-OH与所述脂肪族多异氰酸酯的-NCO的摩尔比为1∶1-2;所述聚丙交酯二醇、所述聚氧化丙烯二醇和所述甲基丙烯酸羟乙酯的总-OH与所述脂肪族多异氰酸酯的-NCO摩尔数相等。The molar ratio of the polylactide diol to the polyoxypropylene diol is 1:0.5-2; The molar ratio of the -NCO of the isocyanate is 1:1-2; the total -OH of the polylactide diol, the polyoxypropylene diol and the hydroxyethyl methacrylate and the - of the aliphatic polyisocyanate NCO moles are equal.
  23. 权利要求13至19中任一项所述光固化材料在制作口腔医疗器械中的应用。Application of the light-curing material described in any one of claims 13 to 19 in making oral medical devices.
  24. 一种口腔医疗器械的制作方法,其特征在于,所述制作方法包括如下步骤:以权利要求13至19中任一项所述光固化材料为原料,通过光固化处理进行成型,得到口腔医疗器械。A method for manufacturing an oral medical device, characterized in that the manufacturing method comprises the following steps: using the light-curing material described in any one of claims 13 to 19 as a raw material, forming it through photo-curing treatment to obtain an oral medical device .
  25. 根据权利要求24所述口腔医疗器械的制作方法,其特征在于,所述成型的方法包括3D打印。The manufacturing method of the oral medical device according to claim 24, wherein the forming method comprises 3D printing.
PCT/CN2022/130021 2021-11-05 2022-11-04 Polyurethane acrylate, photocurable material, preparation method and use WO2023078419A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111308532.8A CN114057975B (en) 2021-11-05 2021-11-05 Low-haze high-toughness polyurethane acrylate, photocuring material, and preparation methods and applications thereof
CN202111308532.8 2021-11-05

Publications (1)

Publication Number Publication Date
WO2023078419A1 true WO2023078419A1 (en) 2023-05-11

Family

ID=80274190

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/130021 WO2023078419A1 (en) 2021-11-05 2022-11-04 Polyurethane acrylate, photocurable material, preparation method and use

Country Status (2)

Country Link
CN (1) CN114057975B (en)
WO (1) WO2023078419A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114057975B (en) * 2021-11-05 2023-03-28 广州黑格智造信息科技有限公司 Low-haze high-toughness polyurethane acrylate, photocuring material, and preparation methods and applications thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605729A (en) * 1984-10-17 1986-08-12 Bayer Aktiengesellschaft Process for the production of polyetherester polyols and the products and use thereof
CN102504223A (en) * 2011-10-27 2012-06-20 山东东大一诺威聚氨酯有限公司 Polyether ester polyhydric alcohol and using method thereof
WO2019185342A1 (en) * 2018-03-28 2019-10-03 Henkel IP & Holding GmbH Three-dimensional articles made by additive manufacturing having reduced surface haze
CN112063352A (en) * 2020-09-08 2020-12-11 湖北回天新材料(宜城)有限公司 Low-odor solvent-free bi-component polyurethane adhesive and preparation method and application thereof
CN113105590A (en) * 2021-04-12 2021-07-13 泉州师范学院 Photosensitive resin composition for photocuring 3D printing elastomer and preparation method thereof
CN114057975A (en) * 2021-11-05 2022-02-18 广州黑格智造信息科技有限公司 Low-haze high-toughness polyurethane acrylate, photocuring material, and preparation methods and applications thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242831A1 (en) * 2003-05-30 2004-12-02 Dong Tian Enzyme catalyzed polyesters and polyol polymers
US20140213677A1 (en) * 2011-10-14 2014-07-31 Dow Global Technologies Llc Hybrid polyester-polyether polyols for improved demold expansion in polyurethane rigid foams
JP2017171891A (en) * 2016-03-18 2017-09-28 宇部興産株式会社 Polyurethane (meth)acrylate, composition, cured article
CN106519161A (en) * 2016-10-25 2017-03-22 深圳光华伟业股份有限公司 Light-cured resin prepolymer, light-cured resin and preparation methods of light-cured resin prepolymer and light-cured resin
CN107880223B (en) * 2017-11-16 2019-12-24 浙江维彬三维科技有限公司 3D printing resin with rapid curing and low shrinkage rate
CN108467480A (en) * 2018-03-22 2018-08-31 上海联景高分子材料有限公司 Polyether-modified polyester polyol and its thermoplastic polyurethane elastomer being polymerized
CN110128773B (en) * 2019-05-07 2021-09-28 杭州师范大学 Light-heat dual-curing 3D printing method and product thereof
CN110791081B (en) * 2019-10-09 2022-05-13 浙江闪铸三维科技有限公司 Preparation method of elastic photosensitive resin for 3D printing
CN110938175A (en) * 2019-10-30 2020-03-31 杭州乐一新材料科技有限公司 Light-heat dual-curing 3D printing method utilizing ring-opening metathesis polymerization and product thereof
CN112043608A (en) * 2020-09-11 2020-12-08 无锡市腰果新材料有限公司 DLP type 3D printing photocuring material for clinical dentistry
CN112220969B (en) * 2020-12-18 2021-03-16 北京大学第三医院(北京大学第三临床医学院) Photocuring 3D printing preparation method of degradable meniscus support

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605729A (en) * 1984-10-17 1986-08-12 Bayer Aktiengesellschaft Process for the production of polyetherester polyols and the products and use thereof
CN102504223A (en) * 2011-10-27 2012-06-20 山东东大一诺威聚氨酯有限公司 Polyether ester polyhydric alcohol and using method thereof
WO2019185342A1 (en) * 2018-03-28 2019-10-03 Henkel IP & Holding GmbH Three-dimensional articles made by additive manufacturing having reduced surface haze
CN112063352A (en) * 2020-09-08 2020-12-11 湖北回天新材料(宜城)有限公司 Low-odor solvent-free bi-component polyurethane adhesive and preparation method and application thereof
CN113105590A (en) * 2021-04-12 2021-07-13 泉州师范学院 Photosensitive resin composition for photocuring 3D printing elastomer and preparation method thereof
CN114057975A (en) * 2021-11-05 2022-02-18 广州黑格智造信息科技有限公司 Low-haze high-toughness polyurethane acrylate, photocuring material, and preparation methods and applications thereof

Also Published As

Publication number Publication date
CN114057975B (en) 2023-03-28
CN114057975A (en) 2022-02-18

Similar Documents

Publication Publication Date Title
US11708428B2 (en) Photopolymerizable compositions including a polyurethane methacrylate polymer prepared using a polycarbonate diol, articles, and methods
US11104758B2 (en) Orthodontic articles prepared using a polycarbonate diol, and methods of making same
US11584817B2 (en) Orthodontic articles comprising cured free-radically polymerizable composition with improved strength in aqueous environment
US20220056258A1 (en) Orthodontic articles comprising polyester urethane (meth)acrylate polymer and monofunctional (meth)acrylate monomer, methods, and polymerizable compositions
WO2019103855A1 (en) Photopolymerizable compositions including a urethane component and a monofunctional reactive diluent, articles, and methods
US20200332046A1 (en) Photopolymerizable compositions including a polypropylene oxide component, articles, and methods
US20210386522A1 (en) Orthodontic articles comprising cured free-radically polymerizable composition comprising polymer or macromolecule with photoinitiator group
US20220242991A1 (en) Orthodontic Articles Comprising Polymerized Composition with Pendent Cyclic Moieties, Methods, and Polymerizable Compositions
WO2023078419A1 (en) Polyurethane acrylate, photocurable material, preparation method and use
WO2023179286A1 (en) Photocuring 3d printing material used for dental model, and preparation method therefor
JPH04235903A (en) Photocurable stamping material
KR20190088097A (en) Photo-curable resin compositions and article using the same
US20230392041A1 (en) Polymerizable composition for dental tooth and material 3d printing
CN115348981A (en) Photocurable composition, cured product, and dental article
WO2020071552A1 (en) Resin composition for optical shaping
KR102213063B1 (en) Photocurable composition for manufacturing flexible elastomers with biocompatibility
JPS63308018A (en) Resin composition and coating agent
CN115403715B (en) 3D printing resin composition for orthodontic appliance, 3D printing product and preparation method thereof
CN115286743A (en) Photocuring resin for high-precision matte 3D printing and preparation method thereof
JP2024065389A (en) Method for producing polyurethane composite material, polyurethane composite material obtained by said method, and method for producing material for dental cutting

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22889440

Country of ref document: EP

Kind code of ref document: A1